Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru mid 2025, so you can switch back as our improvements continue.

Bill Information - History

House Bill 1033; Regular Session 2021-2022

Text

[History]

[Votes]

Sponsors:

RAPP, R. BROWN, ZIMMERMAN, BOROWICZ, ROTHMAN, STAATS, CAUSER, KAUFFMAN, PASHINSKI, RYAN, MALONEY, DeLUCA, SAPPEY, HELM, ROWE, JAMES, BROOKS, MILLARD, PISCIOTTANO, CIRESI, NEILSON, R. MACKENZIE, STRUZZI, WEBSTER, MOUL, SANKEY, WHEELAND, QUINN, M. MACKENZIE, B. MILLER, LAWRENCE, GLEIM, SCHLEGEL CULVER, GILLEN, BERNSTINE, HENNESSEY, DAVANZO and E. NELSON

Printer's No.(PN):

1064*

Short Title:

An Act providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.

Actions:

	PN 1064	Referred to HEALTH, March 26, 2021
		Reported as committed, May 5, 2021
		First consideration, May 5, 2021
		Laid on the table, May 5, 2021
		Removed from table, May 25, 2021
		Second consideration, May 26, 2021
		Re-committed to APPROPRIATIONS, May 26, 2021
		(Remarks see House Journal Page 714-715, 749-750), May 26, 2021
		Re-reported as committed, June 7, 2021
		Third consideration and final passage, June 7, 2021 (136-66)
		(Remarks see House Journal Page 769-771), June 7, 2021
		In the Senate
		Referred to BANKING AND INSURANCE, June 7, 2021

* denotes current Printer's Number

How to Read a Bill About PDF Documents